|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 9/08 | (2013.01) | ||
| A61K 31/69 | (2006.01) | ||
| A61K 31/69 | (2013.01) |
| (11) | Number of the document | 3324937 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16744351.4 |
| Date of filing the European patent application | 2016-07-21 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/067413 |
| Date | 2016-07-21 |
| (87) | Number | WO 2017/013208 |
| Date | 2017-01-26 |
| (30) | Number | Date | Country code |
| 15002163 | 2015-07-22 | EP |
| (72) |
SCHRIDDE, Edgar , DE
|
| (73) |
STADA Arzneimittel AG ,
Stadastrasse 2-18, 61118 Bad Vilbel,
DE
|
| (54) | GEBRAUCHSFERTIGE BORTEZOMIB-LÖSUNG |
| READY-TO-USE SOLUTION OF BORTEZOMIB |